Cargando…
Genetics of rheumatoid arthritis contributes to biology and drug discovery
A major challenge in human genetics is to devise a systematic strategy to integrate disease-associated variants with diverse genomic and biological datasets to provide insight into disease pathogenesis and guide drug discovery for complex traits such as rheumatoid arthritis (RA)(1). Here, we perform...
Ejemplares similares
-
PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease
por: Johansson, Martin, et al.
Publicado: (2006) -
Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis
por: Surowiec, Izabella, et al.
Publicado: (2016) -
Identification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis
por: Xie, Gang, et al.
Publicado: (2013) -
Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
por: Boman, Antonia, et al.
Publicado: (2017) -
Dysregulated microRNA expression in rheumatoid arthritis families—a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls
por: Renman, Emma, et al.
Publicado: (2020)